Commercial metal-based nanocolloids - lack of virucidal activity against ECBO virus

• Autorzy: Malaczewska J. , Siwicki A. K.
• Języki publikacji: EN

Abstrakty

EN

Metallic nanoparticles, mainly silver ones, have been widely used as antibacterial agents, and some studies shown they also exert direct antiviral activity against both enveloped and non-enveloped viruses. The objective of this study has been to evaluate the virucidal activity of commercial silver, gold, copper and platinum nanocolloids, recommended by the manufacturer as antimicrobials, against the ECBO virus, according to Polish Standard PN-EN 14675:2006. The highest experimentally observed decrease in the viral load was 0.875 log, which - when contrasted with the reduction in virus titre of at least 4 log expected from disinfectants - indicates that none of the analyzed nanocolloids had a disinfectant power towards the ECBO virus under the conditions defined by the standard.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2014
• Tom: 17
• Numer: 3
• Opis fizyczny: p.507-509,ref.

Twórcy

autor

Malaczewska J.

• Department of Microbiology and Clinical Immunology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-719 Olsztyn, Poland

autor

Siwicki A. K.

• Department of Microbiology and Clinical Immunology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-719 Olsztyn, Poland

Bibliografia

• Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R (2009) Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem 20: 1497-1502.
• Chen N, Zheng Y, Yin J, Li X, Zheng C (2013) Inhibitory effects of silver nanoparticles against adenovirus type 3 in vitro. J Virol Methods 193: 470-477.
• Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ (2005) Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology 3: 6.
• Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM, Lau GK, Che CM (2008) Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 13: 253-262.
• PKN (2006) PN-EN 14675:2006 Chemical disinfectants and antiseptics - quantitative suspension test for the evaluation of virucidal activity of chemical disinfectants and antiseptics used in the veterinary area - test method and requirements (phase 2, step 1), Polish Committee for Standardization, Warszawa, p 28.
• Rogers JV, Parkinson CV, Choi YW, Speshock JL, Hussain SM (2008) A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation. Nanoscale Res Lett 3: 129-133.
• Shionoiri N, Sato T, Fujimori Y, Nakayama T, Nemoto M, Matsunaga T, Tanaka T (2012) Investigation of the antiviral properties of copper iodide nanoparticles against feline calicivirus. J Biosci Bioeng 113: 580-586.
• Speshock JL, Murdock RC, Braydich-Stolle LK, Schrand AM, Hussain SM (2010) Interaction of silver nanoparticles with Tacaribe virus. J Nanobiotechnology 8: 19.
• Sun L, Singh AK, Vig K, Pillai SR, Singh SR (2008) Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Nanotechnol 4: 149-158.
• Xiang DX, Chen Q, Pang L, Zheng CL (2011) Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods 178: 137-142.

Identyfikatory

DOI

10.2478/pjvs-2014-0073